CIK 0001430306 · Non-accelerated filer<br>Smaller reporting company
Tonix Pharmaceuticals Holding Corp.
Sign in to watch- Ticker
- TNXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 261434750
- Phone
- 212-980-9155
- Business address
- 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
- Former names
- TAMANDARE EXPLORATIONS INC.
- Open-market buys, last 90 days
- $60,455
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$60,455. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-23 | Stillwell Richard Newcomb Director | Grant or award · Stock Option | +104,621 | 104,621 | ||
| 2024-05-23 | OLUKOTUN ADEOYE Y Director | Grant or award · Stock Option | +104,621 | 104,621 | ||
| 2024-05-23 | GRANGE DAVID L Director | Grant or award · Stock Option | +104,621 | 104,621 | ||
| 2024-05-23 | Bell Margaret Smith Director | Grant or award · Stock Option | +104,621 | 104,621 | ||
| 2024-05-23 | BAGGER RICHARD H Director | Grant or award · Stock Option | +104,621 | 104,621 | ||
| 2024-02-27 | LEDERMAN SETH Chief Executive Officer | Grant or award · Stock Option | +235,320 | 235,320 | ||
| 2024-02-27 | LEDERMAN SETH Chief Executive Officer | Grant or award · Stock Option | +1,903,680 | 1,903,680 | ||
| 2024-02-27 | LEDERMAN SETH Chief Executive Officer | Grant or award · Stock Option | +1,309,911 | 1,309,911 | ||
| 2024-02-27 | LEDERMAN SETH Chief Executive Officer | Grant or award · Stock Option | +235,320 | 235,320 | ||
| 2024-02-27 | LEDERMAN SETH Chief Executive Officer | Grant or award · Stock Option | +1,903,680 | 1,903,680 | ||
| 2024-02-27 | LEDERMAN SETH Chief Executive Officer | Grant or award · Stock Option | +1,309,911 | 1,309,911 | ||
| 2024-02-27 | SAENGER BRADLEY Chief Financial Officer | Grant or award · Stock Option | +282,000 | 282,000 | ||
| 2024-02-27 | SAENGER BRADLEY Chief Financial Officer | Grant or award · Stock Option | +282,000 | 282,000 | ||
| 2024-02-27 | MORRIS JESSICA EDGAR Chief Operating Officer | Grant or award · Stock Option | +317,000 | 317,000 | ||
| 2024-02-27 | MORRIS JESSICA EDGAR Chief Operating Officer | Grant or award · Stock Option | +317,000 | 317,000 | ||
| 2024-02-27 | SULLIVAN GREGORY M Chief Medical Officer | Grant or award · Stock Option | +358,000 | 358,000 | ||
| 2024-02-27 | SULLIVAN GREGORY M Chief Medical Officer | Grant or award · Stock Option | +358,000 | 358,000 | ||
| 2023-05-08 | BAGGER RICHARD H Director | Grant or award · Stock Option | +60,000 | 60,000 | ||
| 2023-05-08 | Bell Margaret Smith Director | Grant or award · Stock Option | +60,000 | 60,000 | ||
| 2023-05-08 | GRANGE DAVID L Director | Grant or award · Stock Option | +60,000 | 60,000 |
Page 4 of 25 · 482 trades